In Vivo Toxicology Market by Product (Instruments, Consumables), (Animal models, Reagents & Kits), Testing type (Chronic, Sub-chronic), Toxicity Endpoints (Immunotoxicity, Systemic, DART), Testing Facility - Global Forecast to 2022

  • ID: 4463560
  • Report
  • Region: Global
  • 198 Pages
  • Markets and Markets
1 of 5
The Global In Vivo Toxicology Market is Projected to Grow at a CAGR of 6.9%

FEATURED COMPANIES

  • Danaher
  • Envigo
  • Eurofins Scientific
  • Labcorp
  • Perkinelmer
  • Sri International
  • MORE

“The global In Vivo toxicology market is projected to grow at a CAGR of 6.9%.”

The in vivo toxicology market is expected to reach USD 6.14 billion by 2022 from an estimated USD 4.40 billion in 2017, at a CAGR of 6.9%. The key factors driving the growth of this market include, increasing pharmaceutical R&D activities, mandatory government regulations for animal testing, innovations in animal models, and the development of exclusive in vivo toxicology tests.

On the other hand, alternative methods to animal testing and disadvantages associated with animal toxicology testing likely to restrain the growth of this market.

“The instruments segment is expected to grow at the highest CAGR during the forecast period”

On the basis of product, the in vivo toxicology market is segmented into consumables and instruments. The consumables segment is further divided into reagents & kits and animal models. The instruments segment is expected to grow at the highest rate during the forecast period. The growth of this segment can be attributed to the increasing research on biological samples (such as blood and urine) using bioanalytical equipment.

“Chronic toxicity testing holds the largest share in the global in vivo toxicology market by testing type”

Based on testing type, the global in vivo toxicology market is segmented into acute, sub-acute, sub-chronic, and chronic toxicity testing. In 2017, chronic toxicity testing segment is estimated to hold the largest share in the global in vivo toxicology market. The large share of this market is attributed to the high cost of in vivo testing for more than 90 days, maintaining the animals, quality of tests, and the long duration of the tests performed.

“The immunotoxicity segment is expected to grow at the highest CAGR during the forecast period.”

On the basis of toxicity endpoint, the global in vivo toxicology market is segmented into immunotoxicity, systemic toxicity, carcinogenicity, genotoxicity, developmental and reproductive toxicity (DART), and other toxicity endpoints (includes organ toxicity, endocrine disruptor toxicity, juvenile toxicity, phototoxicity, ocular toxicity, and skin irritation).

In 2017, the immunotoxicity segment is expected to account for the largest share in the in vivo toxicology market, this segment is also expected to grow at the highest CAGR during the forecast period. Rising demand for the development of biologics for autoimmune diseases and cancer and the increasing growth of biosimilars in oncology are driving the growth of this segment. 

“China to witness the highest growth in the APAC region during the forecast period (2017-2022)”

In the APAC region, China is expected to witness the highest growth during the study period. The rising R&D funding and collaborations; initiatives taken by the Chinese government to promote life science research; and the strong trend of commercialization of biotechnology research are contributing to the growth of in vivo toxicology market in China.

Break of primary participants was as mentioned below:

  • By Company Type - Tier 1–29%, Tier 2 - 35% and Tier 3 - 36%
  • By Designation - C - level–39%, Director Level - 35%, Others - 26%
  • By Region - North America - 42%, Europe - 36%, Asia Pacific - 13%, ROW - 9%

The major players in the global in vivo toxicology market are Thermo Fisher (US), Danaher (US), Charles River (US), Covance (LabCorp), and The Jackson Laboratory (US).

Research Coverage:

The report analyzes the in vivo toxicology market and aims at estimating the market size and future growth potential of this market based on various aspects such as products, testing type, toxicity endpoint, testing facility and region. The report also includes the competitive analysis of the key players in this market along with their company profiles, product offerings, recent developments, and key market strategies.
Reasons to Buy the Report

The report will help established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in-turn would help them, garner a greater share of the market. Firms purchasing the report could use one or a  combination of the below-mentioned strategies to strengthen their position in the market.

This report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on product portfolios offered by key players in the global in vivo toxicology market. The report analyzes the global in vivo toxicology market by product, testing type, toxicity endpoint, testing facility, and region
  • Product and Service Innovation: Detailed insights on upcoming trends and product and service launches in the global in vivo toxicology market
  • Market Development: Comprehensive information about the lucrative emerging markets by product, testing type, toxicity endpoint, testing facility, and region
  • Market Diversification: Exhaustive information about new products, growing geographies, recent developments, and investments in the global in vivo toxicology market
  • Competitive Assessment: In-depth assessment of market shares and growth strategies of leading players in the global market
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Danaher
  • Envigo
  • Eurofins Scientific
  • Labcorp
  • Perkinelmer
  • Sri International
  • MORE

1. Introduction
1.1 Objectives Of The Study
1.2 Definition
1.3 Market Scope
1.3.1 Markets Covered
1.4 Years Considered For The Study
1.5 Currency
1.6 Limitations
1.7 Stakeholders

2. Research Methodology
2.1 Research Data
2.2 Market Ranking
2.2.1 Secondary Data
2.2.1.1 Secondary Sources
2.2.2 Primary Data
2.2.2.1 Key Data From Primary Sources
2.2.2.2 Key Industry Insights
2.3 Market Size Estimation
2.3.1 Bottom-Up Approach
2.3.2 Top-Down Approach
2.4 Market Breakdown And Data Triangulation
2.5 Assumptions

3. Executive Summary

4. Premium Insights
4.1 Attractive Opportunities In The In Vivo Toxicology Market
4.2 In Vivo Toxicology Market, By Testing Type
4.3 Europe: In Vivo Toxicology Market, By Toxicity Endpoint And By Country/Region
4.4 In Vivo Toxicology Market: Developing Vs. Developed Countries
4.5 Global In Vivo Toxicology Market: Geographic Snapshot

5. Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Increasing Pharmaceutical R&D Activities
5.2.1.2 Mandatory Government Regulations For Animal Testing
5.2.1.3 Innovations In Animal Models
5.2.1.4 Exclusive In Vivo Toxicology Tests
5.2.2 Restraints
5.2.2.1 Alternative Methods To Animal Testing
5.2.2.2 Disadvantages Associated With Animal Toxicology Testing
5.2.3 Opportunities
5.2.3.1 Increasing Research In Oncology And Personalized Medicine
5.2.3.2 Rising Demand For Humanized Animal Models
5.2.4 Challenges
5.2.4.1 Regulations And Laws For The Ethical Use Of Animals In Research

6. In Vivo Toxicology Market, By Product
6.1 Introduction
6.2 Consumables
6.2.1 Reagents & Kits
6.2.2 Animal Models
6.2.2.1 Mice Models
6.2.2.2 Rat Models
6.2.2.3 Other Animal Models
6.3 Instruments

7. In Vivo Toxicology Market, By Testing Type
7.1 Introduction
7.2 Chronic Toxicity Testing
7.3 Sub-Chronic Toxicity Testing
7.4 Sub-Acute Toxicity Testing
7.5 Acute Toxicity Testing

8. In Vivo Toxicology Market, By Toxicity Endpoint
8.1 Introduction
8.2 Immunotoxicity
8.3 Systemic Toxicity
8.4 Carcinogenicity
8.5 Genotoxicity
8.6 Developmental And Reproductive Toxicity (Dart)
8.7 Other Toxicity Endpoints
 
9. In Vivo Toxicology Market, By Testing Facility
9.1 Introduction
9.2 Outsourced Testing Facilities
9.3 In-House Testing Facilities

10. In Vivo Toxicology Market, By Region
10.1 Introduction
10.2 North America
10.2.1 US
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 France
10.3.4 Rest Of Europe (ROW)
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Rest Of Asia Pacific
10.5 Latin America
10.6 Middle East & Africa

11. Competitive Landscape
11.1 Overview
11.2 Ranking Of Players
11.3 Market Share Analysis
11.4 Competitive Scenario
11.4.1 Product & Service Launches
11.4.2 Collaborations, Partnerships, And Agreements
11.4.3 Acquisitions And Mergers
11.4.4 Expansions
11.4.5 Other Developments
 
12. Company Profiles
(Business Overview, Products Offered, Recent Developments, Swot Analysis, Mnm View)*
12.1 Thermo Fisher Scientific
12.2 Danaher
12.3 Charles River Laboratories
12.4 Labcorp
12.5 The Jackson Laboratory
12.6 Data Sciences International
12.7 Envigo
12.8 Eurofins Scientific
12.9 Perkinelmer
12.10 Sri International
12.11 Taconic Biosciences
12.12 Wuxi Apptec
*Business Overview, Products Offered, Recent Developments, Swot Analysis, Mnm View Might Not Be Captured In Case Of Unlisted Companies.

13. Appendix
13.1 Insights Of Industry Experts
13.2 Discussion Guide
13.3 Knowledge Store: Subscription Portal
13.4 Introducing Rt: Real-Time Market Intelligence
13.5 Related Reports
13.6 Author Details

List Of Tables

Table 1 Innovative Animal Models Developed And Launched By Players
Table 2 Regulatory Authorities Overseeing The Use Of Animal Models In Research
Table 3 In Vivo Toxicology Market, By Product, 2015–2022 (USD Million)
Table 4 In Vivo Toxicology Consumables Market, By Segment, 2015–2022 (USD Million)
Table 5 In Vivo Toxicology Consumables Market, By Country, 2015–2022 (USD Million)
Table 6 Reagents & Kits Market, By Country, 2015–2022 (USD Million)
Table 7 Animal Models Market, By Type, 2015–2022 (USD Million)
Table 8 Animal Models Market, By Country, 2015–2022 (USD Million)
Table 9 Mice Models Market, By Country, 2015–2022 (USD Million)
Table 10 Rat Models Market, By Country, 2015–2022 (USD Million)
Table 11 Other Animal Models Market, By Country, 2015–2022 (USD Million)
Table 12 In Vivo Toxicology Instruments Market, By Country,  2015–2022 (USD Million)
Table 13 In Vivo Toxicology Market, By Type, 2015–2022 (USD Million)
Table 14 Chronic Toxicity Testing Market, By Country, 2015–2022 (USD Million)
Table 15 Sub-Chronic Toxicity Testing Market, By Country, 2015–2022 (USD Million)
Table 16 Sub-Acute Toxicity Testing Market, By Country, 2015–2022 (USD Million)
Table 17 Acute Toxicity Testing Market, By Country, 2015–2022 (USD Million)
Table 18 In Vivo Toxicology Market, By Toxicity Endpoint, 2015–2022 (USD Million)
Table 19 In Vivo Toxicology Market For Immunotoxicity, By Country, 2015–2022 (USD Million)
Table 20 In Vivo Toxicology Market For Systemic Toxicity, By Country, 2015–2022 (USD Million)
Table 21 In Vivo Toxicology Market For Carcinogenicity, By Country, 2015–2022 (USD Million)
Table 22 In Vivo Toxicology Market For Genotoxicity, By Country, 2015–2022 (USD Million)
Table 23 In Vivo Toxicology Market For Developmental And Reproductive Toxicity, By Country, 2015–2022 (USD Million)
Table 24 In Vivo Toxicology Market For Other Toxicity Endpoints, By Country, 2015–2022 (USD Million)
Table 25 In Vivo Toxicology Market, By Testing Facility, 2015–2022 (USD Million)
Table 26 In Vivo Toxicology Market For Outsourced Testing Facilities, By Country, 2015–2022 (USD Million)
Table 27 In Vivo Toxicology Market For In-House Testing Facilities, By Country, 2015–2022 (USD Million)
Table 28 In Vivo Toxicology Market, By Country/Region, 2015–2022 (USD Million)
Table 29 North America: In Vivo Toxicology Market, By Country, 2015–2022 (USD Million)
Table 30 North America: In Vivo Toxicology Market, By Product, 2015–2022 (USD Million)
Table 31 North America: In Vivo Toxicology Consumables Market, By Segment, 2015–2022 (USD Million)
Table 32 North America: In Vivo Toxicology Market For Animal Models, By Type, 2015–2022 (USD Million)
Table 33 North America: In Vivo Toxicology Market, By Testing Type, 2015–2022 (USD Million)
Table 34 North America: In Vivo Toxicology Market, By Toxicity Endpoint, 2015–2022 (USD Million)
Table 35 North America: In Vivo Toxicology Market, By Testing Facility, 2015–2022 (USD Million)
Table 36 Nih Funding For Projects Related To Animal Models
Table 37 US: In Vivo Toxicology Market, By Product, 2015–2022 (USD Million)
Table 38 US: In Vivo Toxicology Consumables Market, By Segment, 2015–2022 (USD Million)
Table 39 US: In Vivo Toxicology Market For Animal Models, By Type, 2015–2022 (USD Million)
Table 40 US: In Vivo Toxicology Market, By Testing Type, 2015–2022 (USD Million)
Table 41 US: In Vivo Toxicology Market, By Toxicity Endpoint, 2015–2022 (USD Million)
Table 42 US: In Vivo Toxicology Market, By Testing Facility, 2015–2022 (USD Million)
Table 43 Canada: In Vivo Toxicology Market, By Product, 2015–2022 (USD Million)
Table 44 Canada: In Vivo Toxicology Consumables Market, By Segment, 2015–2022 (USD Million)
Table 45 Canada: In Vivo Toxicology Market For Animal Models, By Type, 2015–2022 (USD Million)
Table 46 Canada: In Vivo Toxicology Market, By Testing Type, 2015–2022 (USD Million)
Table 47 Canada: In Vivo Toxicology Market, By Toxicity Endpoint, 2015–2022 (USD Million)
Table 48 Canada: In Vivo Toxicology Market, By Testing Facility, 2015–2022 (USD Million)
Table 49 Europe: In Vivo Toxicology Market, By Country, 2015–2022 (USD Million)
Table 50 Europe: In Vivo Toxicology Market, By Product, 2015–2022 (USD Million)
Table 51 Europe: In Vivo Toxicology Consumables Market, By Segment, 2015–2022 (USD Million)
Table 52 Europe: In Vivo Toxicology Market For Animal Models, By Type, 2015–2022 (USD Million)
Table 53 Europe: In Vivo Toxicology Market, By Testing Type, 2015–2022 (USD Million)
Table 54 Europe: In Vivo Toxicology Market, By Toxicity Endpoint, 2015–2022 (USD Million)
Table 55 Europe: In Vivo Toxicology Market, By Testing Facility, 2015–2022 (USD Million)
Table 56 Germany: In Vivo Toxicology Market, By Product, 2015–2022 (USD Million)
Table 57 Germany: In Vivo Toxicology Consumables Market, By Segment, 2015–2022 (USD Million)
Table 58 Germany: In Vivo Toxicology Market For Animal Models, By Type, 2015–2022 (USD Million)
Table 59 Germany: In Vivo Toxicology Market, By Testing Type, 2015–2022 (USD Million)
Table 60 Germany: In Vivo Toxicology Market, By Toxicity Endpoint, 2015–2022 (USD Million)
Table 61 Germany: In Vivo Toxicology Market, By Testing Facility, 2015–2022 (USD Million)
Table 62 UK: In Vivo Toxicology Market, By Product, 2015–2022 (USD Million)
Table 63 UK: In Vivo Toxicology Consumables Market, By Segment, 2015–2022 (USD Million)
Table 64 UK: In Vivo Toxicology Market For Animal Models, By Type, 2015–2022 (USD Million)
Table 65 UK: In Vivo Toxicology Market, By Testing Type, 2015–2022 (USD Million)
Table 66 UK: In Vivo Toxicology Market, By Toxicity Endpoint, 2015–2022 (USD Million)
Table 67 UK: In Vivo Toxicology Market, By Testing Facility, 2015–2022 (USD Million)
Table 68 France: In Vivo Toxicology Market, By Product, 2015–2022 (USD Million)
Table 69 France: In Vivo Toxicology Consumables Market, By Segment, 2015–2022 (USD Million)
Table 70 France: In Vivo Toxicology Market For Animal Models, By Type, 2015–2022 (USD Million)
Table 71 France: In Vivo Toxicology Market, By Testing Type, 2015–2022 (USD Million)
Table 72 France: In Vivo Toxicology Market, By Toxicity Endpoint, 2015–2022 (USD Million)
Table 73 France: In Vivo Toxicology Market, By Testing Facility, 2015–2022 (USD Million)
Table 74 ROE: In Vivo Toxicology Market, By Product, 2015–2022 (USD Million)
Table 75 ROE: In Vivo Toxicology Consumables Market, By Segment, 2015–2022 (USD Million)
Table 76 ROE: In Vivo Toxicology Market For Animal Models, By Type, 2015–2022 (USD Million)
Table 77 ROE: In Vivo Toxicology Market, By Testing Type, 2015–2022 (USD Million)
Table 78 ROE: In Vivo Toxicology Market, By Toxicity Endpoint, 2015–2022 (USD Million)
Table 79 ROE: In Vivo Toxicology Market, By Testing Facility, 2015–2022 (USD Million)
Table 80 Apac: In Vivo Toxicology Market, By Country/Region, 2015–2022 (USD Million)
Table 81 Apac: In Vivo Toxicology Market, By Product, 2015–2022 (USD Million)
Table 82 Apac: In Vivo Toxicology Consumables Market, By Segment,  2015–2022 (USD Million)
Table 83 Apac: In Vivo Toxicology Market For Animal Models, By Type, 2015–2022 (USD Million)
Table 84 Apac: In Vivo Toxicology Market, By Testing Type, 2015–2022 (USD Million)
Table 85 Apac: In Vivo Toxicology Market, By Toxicity Endpoint, 2015–2022 (USD Million)
Table 86 Apac: In Vivo Toxicology Market, By Testing Facility, 2015–2022 (USD Million)
Table 87 Research Collaborations By Foreign-Affiliated Companies And Japanese Universities/Research Institutes (2016)
Table 88 Japan: In Vivo Toxicology Market, By Product, 2015–2022 (USD Million)
Table 89 Japan: In Vivo Toxicology Consumables Market, By Segment, 2015–2022 (USD Million)
Table 90 Japan: In Vivo Toxicology Market For Animal Models, By Type, 2015–2022 (USD Million)
Table 91 Japan: In Vivo Toxicology Market, By Testing Type, 2015–2022 (USD Million)
Table 92 Japan: In Vivo Toxicology Market, By Toxicity Endpoint, 2015–2022 (USD Million)
Table 93 Japan: In Vivo Toxicology Market, By Testing Facility, 2015–2022 (USD Million)
Table 94 China: In Vivo Toxicology Market, By Product, 2015–2022 (USD Million)
Table 95 China: In Vivo Toxicology Consumables Market, By Segment, 2015–2022 (USD Million)
Table 96 China: In Vivo Toxicology Market For Animal Models, By Type, 2015–2022 (USD Million)
Table 97 China: In Vivo Toxicology Market, By Testing Type, 2015–2022 (USD Million)
Table 98 China: In Vivo Toxicology Market, By Toxicity Endpoint, 2015–2022 (USD Million)
Table 99 China: In Vivo Toxicology Market, By Testing Facility, 2015–2022 (USD Million)
Table 100 India: In Vivo Toxicology Market, By Product, 2015–2022 (USD Million)
Table 101 India: In Vivo Toxicology Consumables Market, By Segment, 2015–2022 (USD Million)
Table 102 India: In Vivo Toxicology Market For Animal Models, By Type, 2015–2022 (USD Million)
Table 103 India: In Vivo Toxicology Market, By Testing Type, 2015–2022 (USD Million)
Table 104 India: In Vivo Toxicology Market, By Toxicity Endpoint, 2015–2022 (USD Million)
Table 105 India: In Vivo Toxicology Market, By Testing Facility, 2015–2022 (USD Million)
Table 106 Roapac: In Vivo Toxicology Market, By Product, 2015–2022 (USD Million)
Table 107 Roapac: In Vivo Toxicology Consumables Market, By Segment, 2015–2022 (USD Million)
Table 108 Roapac: In Vivo Toxicology Market For Animal Models, By Type, 2015–2022 (USD Million)
Table 109 Roapac: In Vivo Toxicology Market, By Testing Type, 2015–2022 (USD Million)
Table 110 Roapac: In Vivo Toxicology Market, By Toxicity Endpoint, 2015–2022 (USD Million)
Table 111 Roapac: In Vivo Toxicology Market, By Testing Facility, 2015–2022 (USD Million)
Table 112 Latin America: In Vivo Toxicology Market, By Product, 2015–2022 (USD Million)
Table 113 Latin America: In Vivo Toxicology Consumables Market, By Segment, 2015–2022 (USD Million)
Table 114 Latin America: In Vivo Toxicology Market For Animal Models, By Type, 2015–2022 (USD Million)
Table 115 Latin America: In Vivo Toxicology Market, By Testing Type, 2015–2022 (USD Million)
Table 116 Latin America: In Vivo Toxicology Market, By Toxicity Endpoint, 2015–2022 (USD Million)
Table 117 Latin America: In Vivo Toxicology Market, By Testing Facility, 2015–2022 (USD Million)
Table 118 Middle East & Africa: In Vivo Toxicology Market, By Product, 2015–2022 (USD Million)
Table 119 Middle East & Africa: In Vivo Toxicology Consumables Market, By Segment, 2015–2022 (USD Million)
Table 120 Middle East & Africa: In Vivo Toxicology Market For Animal Models, By Type, 2015–2022 (USD Million)
Table 121 Middle East & Africa: In Vivo Toxicology Market, By Testing Type, 2015–2022 (USD Million)
Table 122 Middle East & Africa: In Vivo Toxicology Market, By Toxicity Endpoint, 2015–2022 (USD Million)
Table 123 Middle East & Africa: In Vivo Toxicology Market, By Testing Facility, 2015–2022 (USD Million)
Table 124 Rank Of Companies In The In Vivo Toxicology Market, By Instruments, 2017

List Of Figures

Figure 1 Research Design
Figure 2 Breakdown Of Primary Interviews: By Company Size, Designation, And Region
Figure 3 Market Data Triangulation Methodology
Figure 4 In Vivo Toxicology Market, By Product, 2017 Vs. 2022 (USD Billion)
Figure 5 In Vivo Toxicology Market, By Testing Type, 2017 Vs. 2022 (USD Billion)
Figure 6 In Vivo Toxicology Market, By Toxicity Endpoint, 2017 Vs. 2022 (USD Billion)
Figure 7 In Vivo Toxicology Market, By Testing Facility,2017 Vs. 2022 (USD Billion)
Figure 8 Geographical Snapshot Of The In Vivo Toxicology Market
Figure 9 Increasing Pharmaceutical R&D Activities And Mandatory Government Regulations For Animal Testing To Drive Market Growth
Figure 10 Chronic Testing Segment To Command The Largest Share In The Market In 2017
Figure 11 Immunotoxicity Segment To Command The Largest Share In The European Market In 2017
Figure 12 Developing Countries To Grow At The Highest Rate From 2017 To 2022
Figure 13 China To Register Highest Growth During The Forecast Period
Figure 14 In Vivo Toxicology Market: Drivers, Restraints, Opportunities, And Challenges
Figure 15 Pharmaceutical R&D Expenditure In The Us, Europe, And Japan 2000—2015)
Figure 16 Consumables Segment Will Continue To Dominate The In Vivo Toxicology Market During The Forecast Period
Figure 17 Chronic Toxicity Testing Segment Will Continue To Dominate The In Vivo Toxicology Market In 2022
Figure 18 Immunotoxicity Segment Will Continue To Dominate The In Vivo Toxicology Market In 2022
Figure 19 Outsourced Testing Facilities Will Continue To Dominate The In Vivo Toxicology Market In 2022
Figure 20 In Vivo Toxicology Market: Geographic Growth Opportunities
Figure 21 North America: In Vivo Toxicology Market Snapshot
Figure 22 Europe: In Vivo Toxicology Market Snapshot
Figure 23 Number Of Cell Therapy Preclinical Studies In The UK (2013–2016)
Figure 24 ROE Countries: Pharmaceutical Industry R&D Expenditure (2015)
Figure 25 Apac: In Vivo Toxicology Market Snapshot
Figure 26 India: R&D Spending By Top Pharma Giants In Fy 2016
Figure 27 Latam: In Vivo Toxicology Market Snapshot
Figure 28 Companies Adopted Product & Service Launches As Their Key Growth Strategy Over The Last Three Years
Figure 29 Global Animal Models Market Share, By Key Player, 2016
Figure 30 Global In Vivo Toxicology Services (Cro) Market Share, By Key Player, 2016
Figure 31 Thermo Fisher Scientific: Company Snapshot
Figure 32 Danaher: Company Snapshot
Figure 33 Charles River Laboratories: Company Snapshot
Figure 34 Labcorp: Company Snapshot
Figure 35 The Jackson Laboratory: Company Snapshot
Figure 36 Envigo: Company Snapshot
Figure 37 Eurofins Scientific: Company Snapshot
Figure 38 Perkinelmer: Company Snapshot

Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
5 of 5
  • Charles River Laboratories
  • Danaher
  • Data Sciences International
  • Envigo
  • Eurofins Scientific
  • Labcorp
  • Perkinelmer
  • Sri International
  • Taconic Biosciences
  • The Jackson Laboratory
  • Wuxi Apptec
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll